BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · SMALL CAP
Cannaisseur Group Inc. TCRG
4 fiscal years on record · USD · FY2025 reported · SEC filings only
$-1.8M
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Growth
USD 0.00
Revenue, FY2025 · full 4-year series below
Revenue $M
Net income $M
FY2025 · Revenue 0.0 · Net income -1.8
-1M-2M
20222025
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
·
Operating margin
Net margin
FY2023 · Operating -357.4% · Net -324.8%
-100%-200%-300%
202220232025
ROE
Not applicable: equity was zero or negative in this period, so return on equity has no meaning.
Three returns, three denominators.
Return on equityNot applicable: equity was zero or negative in this period, so return on equity has no meaning.
Return on assets-179402.7%
Return on capital employedNot applicable: capital employed was zero or negative in this period, so return on capital employed has no meaning.
The 4-year record
4 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative—not applicable◌not available in our data
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue $B | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating income $B | −0.0 | −0.0 | −0.0 | −0.0 |
| EBITDA $B | ◌ | −0.0 | −0.0 | −0.0 |
| Income tax $B | 0.0 | 0.0 | 0.0 | 0.0 |
| Net income $B | −0.0 | −0.0 | −0.0 | −0.0 |
| EPS, diluted $ | −0.03 | −0.03 | 0.00 | 0.00 |
| Dividend / sh $ | ◌ | ◌ | ◌ | ◌ |
| Payout % — not applicable: no dividend | — | — | — | — |
| ROE % — not applicable: negative equity | — | — | — | — |
| Shares out B | 0.06 | 0.04 | 0.04 | 0.04 |
Slide the table for earlier years. "—" not applicable · "◌" not available in our data.
Provenance
Company facts, as filed
How we verify · 0 failures in 18 reconciliationsAUDITED
Reconciled in 4 of the 4 fiscal years we could check. 30 checks were skipped: the balance sheet is not tagged before 2022. 15 checks were skipped: EPS is not tagged before 2022. 15 checks were skipped: revenue is not tagged before 2022.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categoryemerging growth company, smaller reporting company
Data on record since2022